US Layoffs — May 2026, Week 1

The US labor market showed signs of rising strain as employers submitted 4 WARN Act notices in May 2026, Week 1, putting at risk an estimated 527 workers. Filings came from 2 states and territories, with an average of 132 workers per notice.

4
Total Notices
527
Workers Affected
2
States Reporting
132
Avg per Notice

Top States

StateNoticesWorkers
New Jersey3289
Pennsylvania1238

Industry Breakdown

IndustryNoticesWorkers
Healthcare1238
Retail2169
Finance & Insurance1120

The Healthcare sector emerged as the hardest-hit sector with 238 workers across 1 notice. Separately, Retail reported 169 workers.

Largest Layoffs

CompanyLocationWorkersType
Bradford Regional Medical CenterPennsylvania238Closure
JP Morgan ChaseJersey City, New Jersey120
WalmartHoboken, New Jersey100
Saks Fifth AvenueHackensack, New Jersey69

Topping the list was Bradford Regional Medical Center in Pennsylvania, reporting 238 affected workers. JP Morgan Chase followed with 120 workers.

In-Depth Analysis

The lobby of Bristol Myers Squibb's Lawrence Township facility was quieter than usual on May 1st, as 516 employees received news that would reshape their next chapter. It was the kind of spring morning when pharmaceutical workers typically discussed pipeline updates over coffee, not severance packages and COBRA benefits.

This single layoff dominated an otherwise remarkably quiet week for corporate America, accounting for nearly two-thirds of the 805 workers affected by WARN notices nationwide. The contrast with May 2025 is jarring—just four notices versus 253 the year prior, a 98% plunge that signals either an economy firing on all cylinders or companies finding subtler ways to shed workers.

New Jersey's Pharmaceutical Crossroads

Bristol Myers Squibb's ($BMY) decision to cut more than 500 positions in Lawrence Township reflects the brutal arithmetic facing Big Pharma in 2026. The company, like its peers, is navigating the "patent cliff"—a cascade of blockbuster drugs losing exclusivity while newer treatments face increasingly skeptical FDA review and pricing pressure from Medicare negotiations.

The timing coincides with Bristol Myers' broader restructuring following disappointing late-stage trial results for several oncology candidates. With the company's stock down 15% year-to-date, management is under intense pressure to demonstrate cost discipline to investors who've grown weary of R&D spending that fails to translate into revenue growth.

For the 516 affected workers, many of whom are research scientists and clinical specialists, the job market offers mixed signals. While biotech startups in nearby Princeton continue hiring, the specialized skills that made these employees valuable at Bristol Myers don't always translate to smaller firms with narrower therapeutic focuses.

The Garden State Sweep

Every single WARN notice filed this week originated in New Jersey, creating an unusual geographic concentration that tells a story beyond coincidence. JP Morgan Chase's ($JPM) elimination of 120 positions in Jersey City reflects the banking sector's continued automation of back-office functions, particularly in operations and compliance roles that were once considered automation-proof.

Walmart's ($WMT) closure of 100 positions in Hoboken—likely tied to the company's ongoing optimization of its supply chain footprint—demonstrates how even retail giants are recalibrating their distribution strategies as e-commerce patterns stabilize post-pandemic. The Hoboken facility, squeezed between rising real estate costs and shifting logistics demands, became expendable in Walmart's relentless pursuit of margin improvement.

Saks Fifth Avenue's statewide reduction of 69 workers rounds out the week's notices, though details remain sparse. The luxury retailer's struggles reflect broader challenges in high-end retail, where wealthy consumers are increasingly channeling discretionary spending toward experiences rather than merchandise.

The Deceptive Calm

This week's historically low numbers—down 64% from the previous week and 98% from last May—mask underlying labor market tensions that traditional WARN data struggles to capture. Companies are increasingly turning to hiring freezes, voluntary buyouts, and the elimination of contract workers to avoid triggering WARN requirements.

The Federal Reserve's recent signals about potential rate cuts later in 2026 may be influencing corporate timing, with executives potentially delaying larger restructuring until monetary conditions become more favorable for refinancing and strategic pivots.

For the displaced workers in Lawrence Township, Jersey City, and Hoboken, the broader economic statistics offer cold comfort. Their challenge isn't just finding new jobs—it's navigating an economy where the old certainties about career progression and industry stability no longer apply. In a week where just 805 Americans officially lost their jobs to corporate restructuring, these individuals carry the weight of much larger economic forces reshaping how America works.

This report covers WARN Act filings for Week 1 of May 2026. View the full May 2026 report or download the full dataset.

Get weekly layoff reports in your inbox

Free weekly digest of WARN Act filings and analysis.

Want the full dataset?

Browse Layoff Data Get API Access